Antitumor Efficacy of Human Monocyte-Derived Dendritic Cells
Background: Dendritic cells (DCs), which can be used as anti-cancer vaccines, are generally obtained in vitro from isolated CD14+ monocytes (MoDCs). This generates high cell numbers and allows instructing DCs to guarantee effective antitumor responses. However, the impact of the monocyte isolation s...
| Autor principal: | |
|---|---|
| Outros Autores: | , |
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
2018
|
| Assuntos: | |
| Texto completo: | https://doi.org/10.1186/s12575-018-0069-6 |
| País: | Portugal |
| Oai: | oai:run.unl.pt:10362/30948 |